Home › Compare › MCVEF vs GBDC

MCVEF vs GBDC: Dividend Comparison 2026

MCVEF yields 0.62% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.83M in total portfolio value
10 years
MCVEF
MCVEF
● Live price
0.62%
Share price
$27.25
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$64.97
Full MCVEF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — MCVEF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCVEFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCVEF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MCVEF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCVEF
Annual income on $10K today (after 15% tax)
$53.03/yr
After 10yr DRIP, annual income (after tax)
$55.22/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,983,068.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCVEF + GBDC for your $10,000?

MCVEF: 50%GBDC: 50%
100% GBDC50/50100% MCVEF
Portfolio after 10yr
$10.44M
Annual income
$8,225,399.40/yr
Blended yield
78.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

MCVEF
No analyst data
Altman Z
2.3
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCVEF buys
0
GBDC buys
0
No recent congressional trades found for MCVEF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCVEFGBDC
Forward yield0.62%11.86% ✓
Annual dividend / share$0.17$1.50 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$20.6K$20.85M ✓
Annual income after 10y$64.97$16,450,733.83 ✓
Total dividends collected$638.00 ✓$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MCVEF vs GBDC ($10,000, DRIP)

YearMCVEF PortfolioMCVEF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$10,762$62.39$12,492$1,791.70$1.7K → GBDC
2$11,579$62.75$16,527$3,160.58$4.9K → GBDC
3$12,452$63.09$23,588$5,904.90$11.1K → GBDC
4$13,387$63.41$37,141$11,901.65$23.8K → GBDC
5$14,388$63.71$66,205$26,463.38$51.8K → GBDC
6$15,459$64.00$137,452$66,612.65$122.0K → GBDC
7$16,606$64.26$342,372$195,298.53$325.8K → GBDC
8$17,832$64.51$1,053,292$686,954.33$1.04M → GBDC
9$19,145$64.75$4,111,439$2,984,416.95$4.09M → GBDC
10$20,551$64.97$20,849,974$16,450,733.83$20.83M → GBDC

MCVEF vs GBDC: Complete Analysis 2026

MCVEF — Stock

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Full MCVEF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this MCVEF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCVEF vs SCHDMCVEF vs JEPIMCVEF vs OMCVEF vs KOMCVEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.